| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/18/2007 | EP1052259B1 Novel optically active aminopentane derivative |
| 04/18/2007 | EP1037622B1 Taurine derivatives usable in the treatment of retinal disorders |
| 04/18/2007 | EP1024835B1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/18/2007 | EP1017390B1 Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form |
| 04/18/2007 | EP1005374B1 Microparticles for delivery of nucleic acid |
| 04/18/2007 | EP0984001B1 4-organothio-2-cyclopentenones and 3-organothio-2-cyclopentanones, production and pharmaceutical uses thereof |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950397A Therapeutic use of a growth factor, NsG33 |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950391A Crystalline forms of 9-(S)-erythromycylamine |
| 04/18/2007 | CN1950390A Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950388A Macrocyclic compounds and methods of making and using the same |
| 04/18/2007 | CN1950387A Purified, moderately esterified polyol polyester fatty acid compositions and synthesis thereof |
| 04/18/2007 | CN1950383A Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases |
| 04/18/2007 | CN1950381A Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity |
| 04/18/2007 | CN1950380A (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors |
| 04/18/2007 | CN1950379A Thieno[3,2-b]pyridine-6-carbonitriles as protein kinase inhibitors |
| 04/18/2007 | CN1950378A Thienopyridazines as ikk inhibitors |
| 04/18/2007 | CN1950377A Thienopyridines as IKK inhibitors |
| 04/18/2007 | CN1950376A Curcumol derivatives, compositions comprising the same and use in manufacture of medicament |
| 04/18/2007 | CN1950375A Glucocorticoid receptor modulator compounds and methods- utility |
| 04/18/2007 | CN1950374A Tetraazabenzo[e]azulene derivatives and analogs thereof |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950371A Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 04/18/2007 | CN1950370A Enantiomer-pure hexahydro- pyrrolocyclopenta- pyridine derivatives |
| 04/18/2007 | CN1950369A Novel benzothiazoles and the use thereof as medicaments |
| 04/18/2007 | CN1950367A 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors |
| 04/18/2007 | CN1950366A Thioether derivatives, their manufacture and use as pharmaceutical agents |
| 04/18/2007 | CN1950361A Pyrrole or imidazole amides for treating obesity |
| 04/18/2007 | CN1950360A Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 04/18/2007 | CN1950359A Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an IKB kinase inhibitor |
| 04/18/2007 | CN1950358A Novel gamma secretase inhibitors |
| 04/18/2007 | CN1950357A Imidazole derivatives used as TAFIA inhibitors |
| 04/18/2007 | CN1950356A Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 04/18/2007 | CN1950353A Materials and methods for treating coagulation disorders |
| 04/18/2007 | CN1950352A Coumarin derivative and use thereof |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950349A 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/18/2007 | CN1950348A Substituted morpholine compounds for the treatment of central nervous system disorders |
| 04/18/2007 | CN1950346A N-desmethylclozapine crystalline forms |
| 04/18/2007 | CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950342A Novel compounds as opioid receptor modulators |
| 04/18/2007 | CN1950341A Naphthalimide derivatives for the treatment of cancer |
| 04/18/2007 | CN1950337A (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease |
| 04/18/2007 | CN1950335A Novel biaromatic compounds which activate PPAR.gamma.-type receptors, their process of preparation and their use in cosmetic or pharmaceutical compositions |
| 04/18/2007 | CN1950334A Ortho substituted aryl or heteroaryl amide compounds |
| 04/18/2007 | CN1950333A Substituted methyl aryl or heteroaryl amide compounds |
| 04/18/2007 | CN1950332A Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues |
| 04/18/2007 | CN1950331A Polymorphic forms of nateglinide |
| 04/18/2007 | CN1950330A Novel crystalline calcium pantothenate |
| 04/18/2007 | CN1950328A Phenyl indan derivatives |
| 04/18/2007 | CN1950323A Crth2受体拮抗剂 Crth2 receptor antagonist |
| 04/18/2007 | CN1950127A The treatment of respiratory disease |
| 04/18/2007 | CN1950110A Cyclodextrin inclusion complexes of pyrimidine-2,4,6-triones |
| 04/18/2007 | CN1950108A Axon regeneration promoter |
| 04/18/2007 | CN1950104A Medicament for the treatment of fungal infections, particularly aspergillosis |
| 04/18/2007 | CN1950101A Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| 04/18/2007 | CN1950098A Biodegradable polyurethane and polyurethane ureas |
| 04/18/2007 | CN1950097A Compressed pharmaceutical compositions comprising peg and electrolytes |
| 04/18/2007 | CN1950096A Stabilizers for hydrolyzable organic binders |
| 04/18/2007 | CN1950095A Prevention of arterial restenosis with active vitamin D compounds |
| 04/18/2007 | CN1950094A Composition comprising a survivin antisense oligonucleotide and gemcitabine for the treatment of cancer |
| 04/18/2007 | CN1950093A Oral flora-improving agent, antibacterial agent and growth promoter |
| 04/18/2007 | CN1950092A Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| 04/18/2007 | CN1950091A Biodegradable intraocular implants containing prostamides |
| 04/18/2007 | CN1950090A Use of meloxicam formulations in veterinary medicine |
| 04/18/2007 | CN1950089A Morpholine compounds |
| 04/18/2007 | CN1950088A Use of carboxypeptidase G for combating antifolate toxicity |
| 04/18/2007 | CN1950087A Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
| 04/18/2007 | CN1950086A Fluorinated 4-azasteroids as androgen receptor modulators |
| 04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 04/18/2007 | CN1950084A Perhexilin for treating chronic heart failure |
| 04/18/2007 | CN1950083A Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors |
| 04/18/2007 | CN1950082A Bicyclic and bridged nitrogen heterocycles |
| 04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
| 04/18/2007 | CN1950080A Novel compounds for treatment of cardiac arrhythmia and methods of use |
| 04/18/2007 | CN1950079A Pharmaceutical solution formulations containing 17-AAG |
| 04/18/2007 | CN1950078A Counteracting drug-induced obesity using glp-1 agonists |
| 04/18/2007 | CN1950077A Use of peroxisome proliferator activated receptor delta agonists for the treatment of ms and other demyelinating diseases |
| 04/18/2007 | CN1950076A Topical preparation containing ambroxol |
| 04/18/2007 | CN1950075A Medicinal aerosol formulation products with improved chemical stability |
| 04/18/2007 | CN1950071A Novel oral formulations of ospemifene |
| 04/18/2007 | CN1950070A Process for producing medicine |
| 04/18/2007 | CN1950069A Anti-excititoxic sustained release intracular implants and related methods |
| 04/18/2007 | CN1950067A Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision |
| 04/18/2007 | CN1949977A Anti-coronavirus compounds |
| 04/18/2007 | CN1948502A Application of TRPC in screening antitumour medicine and medical use of its inhibitor |
| 04/18/2007 | CN1948332A Glycyrrhetinic acid-30-acylamide derivatives and its use |
| 04/18/2007 | CN1948331A Nitrate derivative of bile acid and its medical use |
| 04/18/2007 | CN1948323A Platinum (II)- anticancer compound using 2-hydroxy-1,3-propane diamine as carrier group |
| 04/18/2007 | CN1948315A Tricycle compounds and its application in making medicine |
| 04/18/2007 | CN1948313A Preparation method of tiemoazoleamine-8-carboxylic acid water soluble derivative, anticancer activity and application in preparing anticancer medicine |
| 04/18/2007 | CN1948306A Fluoroquinolone-oxazolidone derivative, its preparation method and application |
| 04/18/2007 | CN1948305A New dioxo morpholine kind compound, its preparation method and use |
| 04/18/2007 | CN1948304A Heteraryl ring thiosemicarbazone kind compound and its derivative |
| 04/18/2007 | CN1948298A Dopamine D3 acceptor portion agonist and its application |
| 04/18/2007 | CN1948297A Alkylol piperazine derivative optical isomer or its salt and its application |